MLV & Co. Upgrades Cytokinetics (CYTK) to Buy
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $79.17 +0.50%
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Rating Summary:
22 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 12 | New: 24
Join SI Premium – FREE
MLV & Co. upgraded Cytokinetics (NASDAQ: CYTK) from Hold to Buy with a price target of $9.00.
For an analyst ratings summary and ratings history on Cytokinetics click here. For more ratings news on Cytokinetics click here.
Shares of Cytokinetics closed at $3.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seaport Global Securities Upgrades BWX Technologies (BWXT) to Buy
- Wolfe Research Upgrades Kimco (KIM) to Outperform
- Barclays Upgrades Visteon (VC) to Overweight
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
